Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

The FDA has approved a second dipeptidyl peptidase-4 (DPP-4) inhibitor and metformin combination. This follows the approval of sitagliptin/metformin in 2007.

Saxagliptin + Metformin Extended-release Tablets (Kombiglyze XR™)